Newest Issue is Out. Get your exclusive copy today.
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Umoja Biopharma, plans for the construction of new manufacturing facility The new facility will be dedicated for the production of nextgeneration CAR T immunotherapies The stateoftheart facility designed with 146,000 square foot will overcome the production barriers and delivers effective
Nkarta, Inc plans to construct new manufacturing facility The facility will be home for companys headquarters including administrative offices and laboratories for research development activities The facility covering an area of 88,000 square foot facility will be used for supporting research
Artiva Biotherapeutics plans to construct new GMP manufacturing center The facility will be an addition to the Artivas continued research and GMP manufacturing at its partner GC LabCells center The new facility designed with 52,000squarefoot will support to develop and provide safe and effective cancer therapies
Yposkesi plans to open new bioproduction site with an investment of US$71 million 58M The site features two additional production lines with numerous 1000L scale bioreactors In addition, it also includes quality control lab resources, centralized warehouse
Rentschler Biopharma plans to open new manufacturing site that will be an extension to the existing site in Milford, MA site The new stateoftheart facility includes four new 2,000 L singleuse bioreactors and also adds cleanroom space for manufacturing consisting
Tonix Pharmaceuticals Holding Corp, plans to open new manufacturing facility The new RD facility will address Advanced Development Center ADC for vaccine programs The new Advanced Development Center ADC will support research, development and analytical capabilities
Merck plans to invest US$ 317 million 270 million to construct new translational science center and learning center The new project will be located in Darmstadt, Germany
AbCellera plans to open Good Manufacturing Practices GMP manufacturing facility The firstof itskind facility will be located in Canada The new 130,000squarefoot GMPN facility will be constructed on a current vacant twoacre site
Lonza invests US$927 million CHF850 million to construct two nextgeneration mammalian manufacturing facilities The new stateoftheart mammalian facilities will be located in Visp CH and Portsmouth US
Amgen with an investment of US$1 billion plans to open new manufacturing site It will be the second manufacturing plant located in US The new manufacturing facility is designed with most advanced technologies to support the production of medicines
